From: Tumor-targeting, Systemically Delivered Antisense HER-2 Chemosensitizes Human Breast Cancer Xenografts Irrespective of HER-2 Levels
AS HER-2 ODN Concentration
Lipofectin
F-Lip-2
0.1 µ M
0.3 µ M
Fold sensitization to paclitaxel
2.4
4.9
6.7
9
Fold sensitization to docetaxel
2.2
17
7.2
>30